- European Stocks Estimated To Be Trading Below Fair Value By Up To 45.1%
Mar 31, 2026
As the European markets navigate through uncertainties driven by geopolitical tensions and fluctuating energy prices, indices like the STOXX Europe 600 have shown modest gains, while others remain mixed. In this environment, identifying undervalued stocks can be a strategic move for investors looking to capitalize on potential market inefficiencies and long-term growth opportunities amidst economic challenges.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
Name Current Price Fair Value (Est) Discount (Est) Teleste Oyj (HLSE:TLT1V) €3.61 €7.11 49.3% Serviceware (XTRA:SJJ) €12.35 €24.58 49.8% Revenio Group Oyj (HLSE:REG1V) €18.62 €36.77 49.4% Recordati Industria Chimica e Farmaceutica (BIT:REC) €48.90 €95.82 49% Nordisk Bergteknik (OM:NORB B) SEK11.35 SEK22.55 49.7% Navamedic (OB:NAVA) NOK19.40 NOK38.65 49.8% Exel Composites Oyj (HLSE:EXEL) €7.32 €14.47 49.4% Dino Polska (WSE:DNP) PLN33.07 PLN65.65 49.6% Careium (OM:CARE) SEK19.40 SEK38.05 49% B&S Group (ENXTAM:BSGR) €5.85 €11.66 49.8%
Click here to see the full list of 182 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Underneath we present a selection of stocks filtered out by our screen.
Laboratorios Farmaceuticos Rovi
Overview: Laboratorios Farmaceuticos Rovi, S.A. is a pharmaceutical company that manufactures, sells, and markets products in Spain, the European Union, OECD countries, and internationally with a market cap of €4.08 billion.
Operations: The company generates revenue through its Marketing segment, which accounts for €473.89 million, and its Manufacturing segment, contributing €494.13 million.
Estimated Discount To Fair Value: 45.1%
Laboratorios Farmaceuticos Rovi, trading at €79.8, is significantly undervalued based on future cash flow estimates of €145.46. Despite a slight decline in 2025 sales to €743.48 million, net income rose to €140.44 million, with earnings per share increasing to €2.75 from the previous year. The company forecasts high single-digit to low double-digit revenue growth for 2026 and plans a dividend distribution of over €49 million for 2025 profits.
In light of our recent growth report, it seems possible that Laboratorios Farmaceuticos Rovi's financial performance will exceed current levels. Click here to discover the nuances of Laboratorios Farmaceuticos Rovi with our detailed financial health report.BME:ROVI Discounted Cash Flow as at Mar 2026
Elkem
Overview: Elkem ASA provides advanced material solutions globally and has a market cap of NOK17.95 billion.
Operations: The company generates revenue from Carbon Solutions at NOK3.26 billion and Silicon Products (including Foundry Products) at NOK13.54 billion.
Story Continues
Estimated Discount To Fair Value: 36.6%
Elkem ASA, trading at NOK 28.3, is undervalued with a future cash flow value estimate of NOK 44.65. Despite recent restructuring and cost-cutting measures following the Silicones transaction, Elkem's earnings are expected to grow significantly over the next three years, outpacing the Norwegian market growth rate. However, challenges remain as profit margins have decreased from last year and net losses were reported for 2025 amidst adverse market conditions impacting revenue streams.
Our comprehensive growth report raises the possibility that Elkem is poised for substantial financial growth. Navigate through the intricacies of Elkem with our comprehensive financial health report here.OB:ELK Discounted Cash Flow as at Mar 2026
Colt CZ Group
Overview: Colt CZ Group SE, along with its subsidiaries, is involved in the production and sale of firearms, ammunition products, and tactical accessories across various regions including the Czech Republic, Canada, the United States, Europe, Africa, Asia and internationally; it has a market cap of CZK56.56 billion.
Operations: Colt CZ Group SE generates revenue through the production and sale of firearms, ammunition products, and tactical accessories across multiple regions including the Czech Republic, Canada, the United States, Europe, Africa, Asia, and internationally.
Estimated Discount To Fair Value: 28.2%
Colt CZ Group, trading at CZK 903, is significantly undervalued with a future cash flow value estimate of CZK 1258.28. The company's earnings grew by 95.8% last year and are projected to rise by 25.83% annually, outpacing the Czech market's growth rate. Despite an unstable dividend track record and low forecasted return on equity (14.3%), recent results show strong sales growth to CZK 390.85 million and net income doubling from the previous year.
Our expertly prepared growth report on Colt CZ Group implies its future financial outlook may be stronger than recent results. Dive into the specifics of Colt CZ Group here with our thorough financial health report.SEP:CZG Discounted Cash Flow as at Mar 2026
Make It Happen
Delve into our full catalog of 182 Undervalued European Stocks Based On Cash Flows here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Discover a world of investment opportunities with Simply Wall St's free app and access unparalleled stock analysis across all markets.
Ready For A Different Approach?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include BME:ROVI OB:ELK and SEP:CZG.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- March 2026 European Stocks Trading At Estimated Discounts
Mar 31, 2026
As European markets navigate the uncertainty surrounding the Middle East conflict and its impact on economic growth, investors are keenly observing how these developments influence stock valuations. In this context, identifying undervalued stocks becomes crucial, as they may present opportunities for those looking to capitalize on potential market inefficiencies amid ongoing geopolitical and economic challenges.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
Name Current Price Fair Value (Est) Discount (Est) Teleste Oyj (HLSE:TLT1V) €3.61 €7.11 49.3% Serviceware (XTRA:SJJ) €12.35 €24.58 49.8% Revenio Group Oyj (HLSE:REG1V) €18.62 €36.77 49.4% Recordati Industria Chimica e Farmaceutica (BIT:REC) €48.90 €95.82 49% Nordisk Bergteknik (OM:NORB B) SEK11.35 SEK22.55 49.7% Navamedic (OB:NAVA) NOK19.40 NOK38.65 49.8% Exel Composites Oyj (HLSE:EXEL) €7.32 €14.47 49.4% Dino Polska (WSE:DNP) PLN33.07 PLN65.65 49.6% Careium (OM:CARE) SEK19.40 SEK38.05 49% B&S Group (ENXTAM:BSGR) €5.85 €11.66 49.8%
Click here to see the full list of 182 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Below we spotlight a couple of our favorites from our exclusive screener.
Asmodee Group
Overview: Asmodee Group AB (publ) is involved in the publishing and distribution of tabletop games, with a market cap of approximately SEK24.38 billion.
Operations: The company generates revenue primarily from its Games & Toys segment, totaling €1.62 billion.
Estimated Discount To Fair Value: 39.5%
Asmodee Group appears undervalued based on cash flows, trading at 39.5% below its estimated fair value of SEK172.57, with analysts forecasting a significant stock price increase of 51.9%. Despite a low forecasted return on equity of 8.6%, the company has become profitable and expects earnings growth of 36.6% annually, outpacing the Swedish market's growth rate. Recent strategic expansions into Japan and partnerships like Netflix adaptations could further bolster revenue streams without materially impacting current financial performance.
Insights from our recent growth report point to a promising forecast for Asmodee Group's business outlook. Navigate through the intricacies of Asmodee Group with our comprehensive financial health report here.OM:ASMDEE B Discounted Cash Flow as at Mar 2026
Vimian Group
Overview: Vimian Group AB (publ) operates in the global animal health sector and has a market cap of SEK14.61 billion.
Operations: The company's revenue segments are comprised of Medtech (€155.50 million), Diagnostics (€22.90 million), Specialty Pharma (€182.40 million), and Veterinary Services (€64.50 million).
Estimated Discount To Fair Value: 21.3%
Story Continues
Vimian Group is trading at SEK27.6, below its estimated future cash flow value of SEK35.09, highlighting its undervaluation based on cash flows. The company forecasts a robust annual earnings growth of 28%, surpassing the Swedish market's 9.4%. However, while revenue is expected to grow at 8.7% annually—faster than the market—it remains slower than significant growth benchmarks and faces a forecasted low return on equity of 9.2%.
Upon reviewing our latest growth report, Vimian Group's projected financial performance appears quite optimistic. Unlock comprehensive insights into our analysis of Vimian Group stock in this financial health report.OM:VIMIAN Discounted Cash Flow as at Mar 2026
Verisure
Overview: Verisure plc offers security services for families and small businesses across Europe and Latin America, with a market cap of €9.04 billion.
Operations: The company's revenue segments include Portfolio Services at €3.27 billion, Customer Acquisition at €362.20 million, and Adjacencies at €115.40 million.
Estimated Discount To Fair Value: 12.1%
Verisure is trading at €8.75, below its estimated future cash flow value of €9.95, indicating undervaluation based on cash flows. While revenue grew by 9.9% last year and is forecast to outpace the Swedish market at 8.4% annually, profitability remains a challenge with recent net losses and low return on equity forecasts of 9.2%. Analysts expect significant stock price appreciation, with a forecasted annual earnings growth of over 61%.
According our earnings growth report, there's an indication that Verisure might be ready to expand. Click to explore a detailed breakdown of our findings in Verisure's balance sheet health report.OM:VSURE Discounted Cash Flow as at Mar 2026
Where To Now?
Investigate our full lineup of 182 Undervalued European Stocks Based On Cash Flows right here. Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments. Streamline your investment strategy with Simply Wall St's app for free and benefit from extensive research on stocks across all corners of the world.
Searching for a Fresh Perspective?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include OM:ASMDEE B OM:VIMIAN and OM:VSURE.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- European Value Stocks Trading Below Estimated Worth In February 2026
Feb 5, 2026
As the European markets navigate a landscape marked by earnings optimism amidst trade and geopolitical concerns, the pan-European STOXX Europe 600 Index has shown resilience with modest gains. Against this backdrop, identifying stocks that are trading below their estimated worth can offer potential opportunities for investors seeking value in an environment where confidence is strengthening and economic recovery continues at a steady pace.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
Name Current Price Fair Value (Est) Discount (Est) XTPL (WSE:XTP) PLN68.80 PLN134.93 49% Unimot (WSE:UNT) PLN132.60 PLN260.65 49.1% TTS (Transport Trade Services) (BVB:TTS) RON6.10 RON12.06 49.4% Mips (OM:MIPS) SEK283.00 SEK560.40 49.5% Kreate Group Oyj (HLSE:KREATE) €12.95 €25.33 48.9% Dustin Group (OM:DUST) SEK1.655 SEK3.25 49.1% cyan (XTRA:CYR) €2.26 €4.52 50% Cambi (OB:CAMBI) NOK17.80 NOK35.37 49.7% B&S Group (ENXTAM:BSGR) €5.85 €11.66 49.8% Benefit Systems (WSE:BFT) PLN3905.00 PLN7651.14 49%
Click here to see the full list of 213 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Let's dive into some prime choices out of the screener.
Coloplast
Overview: Coloplast A/S develops and sells intimate healthcare products and services across Denmark, the United States, the United Kingdom, France, and internationally, with a market cap of DKK121.74 billion.
Operations: The company's revenue is segmented into Biologics (DKK1.25 billion), Chronic Care (DKK18.88 billion), Interventional Urology (DKK2.78 billion), Advanced Wound Dressings (DKK2.68 billion), and Voice and Respiratory Care (DKK2.28 billion).
Estimated Discount To Fair Value: 34.4%
Coloplast is trading at DKK540.2, significantly below its estimated future cash flow value of DKK823.39, suggesting it may be undervalued based on cash flows. Analysts agree the stock price could rise by 21.4%, with earnings growth forecasted at 13.8% annually, outpacing the Danish market's average. However, the dividend yield of 4.26% is not well covered by earnings or free cash flows, and profit margins have decreased from last year’s figures amidst high debt levels and leadership changes impacting strategic direction.
Our growth report here indicates Coloplast may be poised for an improving outlook. Take a closer look at Coloplast's balance sheet health here in our report.CPSE:COLO B Discounted Cash Flow as at Feb 2026
Huber+Suhner
Overview: Huber+Suhner AG provides electrical and optical connectivity components and system solutions, with a market cap of CHF3.10 billion.
Operations: The company's revenue is derived from three main segments: Industry (CHF296.90 million), Communication (CHF351.69 million), and Transportation (CHF260.62 million).
Story Continues
Estimated Discount To Fair Value: 17.1%
Huber+Suhner is trading at CHF168.2, slightly below its estimated future cash flow value of CHF202.96, highlighting potential undervaluation based on cash flows. Despite a 3% sales decline in 2025 due to currency effects, earnings are projected to grow significantly at 23.33% annually over the next three years, outpacing the Swiss market's average growth rate of 9.8%. The company anticipates an EBIT margin of 10-11%, aligning with its medium-term targets amidst recent volatility in share price.
Our expertly prepared growth report on Huber+Suhner implies its future financial outlook may be stronger than recent results. Unlock comprehensive insights into our analysis of Huber+Suhner stock in this financial health report.SWX:HUBN Discounted Cash Flow as at Feb 2026
Dino Polska
Overview: Dino Polska S.A. operates a network of medium-sized grocery supermarkets under the Dino brand in Poland and has a market cap of PLN39.03 billion.
Operations: The company generates revenue primarily through its retail network and online sales, amounting to PLN32.24 billion.
Estimated Discount To Fair Value: 33.1%
Dino Polska is trading at PLN39.81, significantly below its estimated future cash flow value of PLN59.51, suggesting it is undervalued based on cash flows. Recent earnings results show net income growth to PLN481.87 million for Q3 2025, up from PLN438.21 million a year ago, with sales increasing to PLN8.76 billion from PLN7.61 billion in the same period, supporting an expectation of significant annual earnings growth over the next three years above market averages in Poland.
Our comprehensive growth report raises the possibility that Dino Polska is poised for substantial financial growth. Click here and access our complete balance sheet health report to understand the dynamics of Dino Polska.WSE:DNP Discounted Cash Flow as at Feb 2026
Where To Now?
Dive into all 213 of the Undervalued European Stocks Based On Cash Flows we have identified here. Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Want To Explore Some Alternatives?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include CPSE:COLO B SWX:HUBN and WSE:DNP.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- Basic-Fit And 2 Other European Stocks That Might Be Priced Below Their Estimated Value
Dec 19, 2025
As European markets display mixed performance, with indices like Germany's DAX showing gains while others such as France's CAC 40 experience declines, investors are keenly observing the potential for undervalued opportunities amidst economic uncertainties. In this environment, identifying stocks that may be priced below their estimated value becomes crucial, as these can offer potential upside in a market where central bank policies and economic data continue to influence investor sentiment.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
Name Current Price Fair Value (Est) Discount (Est) Unimot (WSE:UNT) PLN129.00 PLN257.76 50% Truecaller (OM:TRUE B) SEK18.60 SEK36.55 49.1% Straumann Holding (SWX:STMN) CHF94.42 CHF187.49 49.6% Outokumpu Oyj (HLSE:OUT1V) €4.348 €8.54 49.1% Kitron (OB:KIT) NOK68.05 NOK135.42 49.7% Jæren Sparebank (OB:JAREN) NOK378.00 NOK752.65 49.8% Inission (OM:INISS B) SEK48.90 SEK97.00 49.6% cyan (XTRA:CYR) €2.28 €4.51 49.5% Circle (BIT:CIRC) €8.00 €15.74 49.2% Allegro.eu (WSE:ALE) PLN30.535 PLN60.33 49.4%
Click here to see the full list of 193 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Here's a peek at a few of the choices from the screener.
Basic-Fit
Overview: Basic-Fit N.V., with a market cap of €1.91 billion, operates fitness clubs through its subsidiaries.
Operations: The company's revenue is derived from its operations in the Benelux region, contributing €541.70 million, and from France, Spain, and Germany, which together generate €766 million.
Estimated Discount To Fair Value: 25.5%
Basic-Fit is trading at €29.22, 25.5% below its estimated fair value of €39.22, highlighting its undervaluation based on discounted cash flows. The company reported a significant revenue increase to €1.034 billion for the first nine months of 2025, up 60% from the previous year, and reaffirmed its annual revenue guidance between €1.375 billion and €1.425 billion. Earnings are forecast to grow annually by 46.77%, with profitability expected in three years, surpassing market averages.
Upon reviewing our latest growth report, Basic-Fit's projected financial performance appears quite optimistic. Delve into the full analysis health report here for a deeper understanding of Basic-Fit.ENXTAM:BFIT Discounted Cash Flow as at Dec 2025
SMG Swiss Marketplace Group Holding
Overview: SMG Swiss Marketplace Group Holding AG is an online marketplace and digital company offering decision-making tools in Switzerland, with a market cap of CHF3.24 billion.
Operations: The company's revenue is derived from three main segments: Automotive (CHF81.33 million), Real Estate (CHF169.27 million), and General Marketplaces (CHF76.51 million).
Story Continues
Estimated Discount To Fair Value: 37.5%
SMG Swiss Marketplace Group Holding, trading at CHF33.05, is significantly undervalued with a fair value estimate of CHF52.86. Analysts agree on a potential 43.3% price increase, supported by strong earnings growth forecasts of 24.8% annually over the next three years, outpacing the Swiss market's 10.5%. Despite recent share price volatility and a modest revenue growth forecast of 8.7%, SMG remains attractive due to its robust cash flow valuation and profit outlook.
The growth report we've compiled suggests that SMG Swiss Marketplace Group Holding's future prospects could be on the up. Click here to discover the nuances of SMG Swiss Marketplace Group Holding with our detailed financial health report.SWX:SMG Discounted Cash Flow as at Dec 2025
Dino Polska
Overview: Dino Polska S.A., along with its subsidiaries, operates a network of medium-sized grocery supermarkets under the Dino brand in Poland and has a market cap of PLN39.99 billion.
Operations: The company's revenue primarily comes from Sales In The Retail Network and Online Sales, amounting to PLN32.24 billion.
Estimated Discount To Fair Value: 42.4%
Dino Polska is trading at PLN 40.79, significantly below its estimated fair value of PLN 70.81, indicating it may be undervalued based on cash flows. The company reported strong earnings growth with net income rising to PLN 481.87 million in Q3 2025 from PLN 438.21 million a year ago, and forecasts suggest annual profit growth of over 20%, outpacing the Polish market's average. Analysts anticipate a potential price increase of around 23.6%.
The analysis detailed in our Dino Polska growth report hints at robust future financial performance. Get an in-depth perspective on Dino Polska's balance sheet by reading our health report here.WSE:DNP Discounted Cash Flow as at Dec 2025
Seize The Opportunity
Take a closer look at our Undervalued European Stocks Based On Cash Flows list of 193 companies by clicking here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.
Curious About Other Options?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ENXTAM:BFIT SWX:SMG and WSE:DNP.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- European Growth Stocks With Insider Ownership Expecting 41% Earnings Growth
Dec 11, 2025
As the European market navigates a landscape of mixed returns and fluctuating economic indicators, investor optimism is buoyed by hopes for interest rate cuts in major economies. In this environment, growth companies with high insider ownership stand out as potentially strong contenders due to their alignment of interests between management and shareholders, particularly when anticipating significant earnings growth.
Top 10 Growth Companies With High Insider Ownership In Europe
Name Insider Ownership Earnings Growth Warimpex Finanz- und Beteiligungs (WBAG:WXF) 25.9% 100.6% Redelfi (BIT:RDF) 12.4% 39.1% MilDef Group (OM:MILDEF) 13.7% 83% MedinCell (ENXTPA:MEDCL) 12.5% 95.4% Magnora (OB:MGN) 10.4% 75.1% KebNi (OM:KEBNI B) 36.3% 61.2% DNO (OB:DNO) 13.5% 97.5% CTT Systems (OM:CTT) 17.5% 52% Circus (XTRA:CA1) 24.1% 65.8% Bonesupport Holding (OM:BONEX) 10.4% 49.6%
Click here to see the full list of 208 stocks from our Fast Growing European Companies With High Insider Ownership screener.
Let's review some notable picks from our screened stocks.
ACS Actividades de Construcción y Servicios
Simply Wall St Growth Rating: ★★★★☆☆
Overview: ACS Actividades de Construcción y Servicios (BME:ACS) is a global construction and services company with a market cap of €22.04 billion, engaged in infrastructure development, civil engineering, and industrial services.
Operations: ACS generates its revenue from several key segments: Cimic (€11.11 billion), Turner (€24.44 billion), Infrastructure (€241.67 million), and Engineering and Construction (€10.30 billion).
Insider Ownership: 14.4%
Earnings Growth Forecast: 13% p.a.
ACS Actividades de Construcción y Servicios has demonstrated robust revenue growth, reporting €36.75 billion for the first nine months of 2025, up from €29.70 billion a year ago. Despite large one-off items affecting earnings quality, its forecasted annual earnings growth of 13% surpasses the Spanish market's average. While insider trading data is lacking, ACS trades at a discount to fair value and maintains high forecasted return on equity at 20.8%.
Take a closer look at ACS Actividades de Construcción y Servicios' potential here in our earnings growth report. The analysis detailed in our ACS Actividades de Construcción y Servicios valuation report hints at an inflated share price compared to its estimated value.BME:ACS Ownership Breakdown as at Dec 2025
Absolent Air Care Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Absolent Air Care Group AB (publ) is involved in the design, development, sale, installation, and maintenance of air filtration units and has a market cap of SEK2.42 billion.
Operations: The company's revenue is primarily derived from its Industrial segment, which accounts for SEK1029.08 million, and the Commercial Kitchen segment, contributing SEK243.58 million.
Story continues
Insider Ownership: 12.6%
Earnings Growth Forecast: 42% p.a.
Absolent Air Care Group, with significant insider buying in recent months, reported a slight increase in third-quarter net income to SEK 19.98 million despite a decline in sales. The company trades at a notable discount to its estimated fair value and is expected to achieve substantial earnings growth of 42% annually, outpacing the Swedish market's average. However, revenue growth forecasts remain modest at 10.2% per year compared to higher benchmarks for rapid expansion.
Click here and access our complete growth analysis report to understand the dynamics of Absolent Air Care Group. Insights from our recent valuation report point to the potential undervaluation of Absolent Air Care Group shares in the market.OM:ABSO Earnings and Revenue Growth as at Dec 2025
Dino Polska
Simply Wall St Growth Rating: ★★★★★☆
Overview: Dino Polska S.A. operates a network of medium-sized grocery supermarkets under the Dino brand in Poland and has a market cap of PLN39.46 billion.
Operations: The company's revenue primarily comes from sales in its retail network and online channels, totaling PLN32.24 billion.
Insider Ownership: 27%
Earnings Growth Forecast: 20.5% p.a.
Dino Polska's earnings have grown by 12.9% in the past year and are expected to increase significantly at 20.5% annually over the next three years, outpacing Polish market growth. Despite no recent insider trading activity, it trades at a substantial discount of 43.2% below estimated fair value. Recent earnings reports show strong performance with third-quarter sales of PLN 8.76 billion and net income rising to PLN 481.87 million from last year’s PLN 438.21 million.
Unlock comprehensive insights into our analysis of Dino Polska stock in this growth report. Our valuation report unveils the possibility Dino Polska's shares may be trading at a discount.WSE:DNP Earnings and Revenue Growth as at Dec 2025
Next Steps
Discover the full array of 208 Fast Growing European Companies With High Insider Ownership right here. Looking For Alternative Opportunities? The end of cancer? These 29 emerging AI stocks are developing tech that will allow early idenification of life changing disesaes like cancer and Alzheimer's.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include BME:ACS OM:ABSO and WSE:DNP.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View comments
- European Value Stocks That Might Be Trading At A Discount In November 2025
Nov 20, 2025
As European markets navigate a complex landscape marked by relief from the U.S. government reopening and tempered enthusiasm around artificial intelligence, investors are keenly observing opportunities for value amidst fluctuating economic indicators. In this environment, identifying undervalued stocks requires a focus on companies with strong fundamentals that may be overlooked due to broader market sentiment or temporary economic challenges.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
Name Current Price Fair Value (Est) Discount (Est) STEICO (XTRA:ST5) €20.15 €40.14 49.8% Spindox (BIT:SPN) €12.90 €25.30 49% Roche Bobois (ENXTPA:RBO) €35.10 €69.87 49.8% NOBA Bank Group (OM:NOBA) SEK100.02 SEK198.21 49.5% NEUCA (WSE:NEU) PLN784.00 PLN1553.92 49.5% Kitron (OB:KIT) NOK65.00 NOK127.02 48.8% KB Components (OM:KBC) SEK41.70 SEK81.65 48.9% Exel Composites Oyj (HLSE:EXL1V) €0.394 €0.78 49.8% Allcore (BIT:CORE) €1.33 €2.66 50% Absolent Air Care Group (OM:ABSO) SEK205.00 SEK401.16 48.9%
Click here to see the full list of 193 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Here we highlight a subset of our preferred stocks from the screener.
SMG Swiss Marketplace Group Holding
Overview: SMG Swiss Marketplace Group Holding AG operates as an online marketplace and digital company offering decision-making tools in Switzerland, with a market capitalization of CHF3.21 billion.
Operations: The company's revenue segments include Automotive at CHF81.33 million, Real Estate at CHF169.27 million, and General Marketplaces at CHF76.51 million.
Estimated Discount To Fair Value: 38%
SMG Swiss Marketplace Group Holding, trading at CHF32.7, is significantly undervalued against its estimated fair value of CHF52.71, offering a compelling opportunity based on discounted cash flow analysis. Earnings are projected to grow by 25% annually over the next three years, outpacing the Swiss market's growth rate. Despite recent IPO activities raising CHF902.94 million and share price volatility, analysts agree on a potential 53.6% price increase from current levels.
Our growth report here indicates SMG Swiss Marketplace Group Holding may be poised for an improving outlook. Take a closer look at SMG Swiss Marketplace Group Holding's balance sheet health here in our report.SWX:SMG Discounted Cash Flow as at Nov 2025
Dino Polska
Overview: Dino Polska S.A. operates a network of medium-sized grocery supermarkets under the Dino brand in Poland and has a market cap of PLN40.97 billion.
Operations: The company's revenue primarily comes from sales in its retail network and online sales, amounting to PLN32.24 billion.
Story Continues
Estimated Discount To Fair Value: 41%
Dino Polska, trading at PLN41.79, is significantly undervalued with an estimated fair value of PLN70.81, presenting a strong case based on discounted cash flow analysis. Earnings are expected to grow over 20% annually in the next three years, surpassing the Polish market's growth rate of 15.4%. Recent earnings reports show consistent revenue and net income growth year-over-year, reinforcing its potential as an undervalued investment opportunity in Europe.
In light of our recent growth report, it seems possible that Dino Polska's financial performance will exceed current levels. Click to explore a detailed breakdown of our findings in Dino Polska's balance sheet health report.WSE:DNP Discounted Cash Flow as at Nov 2025
Ottobock SE KGaA
Overview: Ottobock SE & Co. KGaA specializes in designing and developing medical technology products for individuals with limited mobility, focusing on prosthetics, orthotics, human mobility, and medical care globally, with a market cap of €4.72 billion.
Operations: The company's revenue is derived from its focus on prosthetics, orthotics, human mobility, and medical care solutions for individuals with limited mobility.
Estimated Discount To Fair Value: 16.3%
Ottobock SE KGaA, trading at €73.70, is undervalued with an estimated fair value of €88.04 based on discounted cash flow analysis. Recent earnings reports reveal sales and net income growth year-over-year, with a notable 68.4% increase in earnings last year and forecasts predicting significant annual profit growth of over 20% for the next three years. Despite this potential, interest payments are not well covered by earnings, indicating financial caution is warranted.
According our earnings growth report, there's an indication that Ottobock SE KGaA might be ready to expand. Click here to discover the nuances of Ottobock SE KGaA with our detailed financial health report.XTRA:OBCK Discounted Cash Flow as at Nov 2025
Summing It All Up
Reveal the 193 hidden gems among our Undervalued European Stocks Based On Cash Flows screener with a single click here. Are you invested in these stocks already? Keep abreast of every twist and turn by setting up a portfolio with Simply Wall St, where we make it simple for investors like you to stay informed and proactive. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Interested In Other Possibilities?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include SWX:SMG WSE:DNP and XTRA:OBCK.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- Baron International Growth Fund initiated NMR, ESLOF, PONY, GDS, and KUASF; exits YAHOF, DNOPF, and CIADF.
Nov 7, 2025
* Baron International Growth Fund gained 6.04%, slightly underperforming its benchmark MSCI ACWI ex USA Index, which appreciated 6.89%. However, the fund bettered its proxy benchmark, the MSCI ACWI ex USA IMI Growth Index, which gained 5.75% during Q3 2025.
* The fund initiated a position in Nomura (NMR [https://seekingalpha.com/symbol/NMR]), EssilorLuxottica (OTCPK:ESLOF [https://seekingalpha.com/symbol/ESLOF]), Pony AI (PONY [https://seekingalpha.com/symbol/PONY]), GDS (GDS [https://seekingalpha.com/symbol/GDS]), and Kuaishou Technology (OTCPK:KUASF [https://seekingalpha.com/symbol/KUASF]) in Q3 2025.
* The fund exited a few positions during the quarter, including LY (OTCPK:YAHOF [https://seekingalpha.com/symbol/YAHOF]), Dino Polska (OTCPK:DNOPF [https://seekingalpha.com/symbol/DNOPF]), China Mengniu Dairy (OTCPK:CIADF [https://seekingalpha.com/symbol/CIADF]), and Indus Towers.
* Source [https://seekingalpha.com/article/4839052-baron-international-growth-fund-q3-2025-portfolio-update].
MORE ON
* Lord Abbett Developing Growth Fund Q3 2025 Commentary [https://seekingalpha.com/article/4840207-lord-abbett-developing-growth-fund-q3-2025-commentary]
* Trinity Capital: One Of The Best 'Buy The Dip' Moments In The BDC Space [https://seekingalpha.com/article/4840054-trinity-capital-one-of-the-best-buy-the-dip-moments-in-bdc-space]
* Don't Blame The Decline In Stock Prices On Layoffs [https://seekingalpha.com/article/4840202-dont-blame-decline-in-stock-prices-on-layoffs]
* PNC Bank boosts branch expansion drive by 100, bringing total investment to $2B [https://seekingalpha.com/news/4518582-pnc-bank-boosts-branch-expansion-drive-by-100-bringing-total-investment-to-2b]
* BlackLine getting pressure from more investors to pursue a sale - report [https://seekingalpha.com/news/4518585-blackline-getting-pressure-from-more-investors-to-pursue-a-sale-report]
- European Value Stock Insights For October 2025
Oct 9, 2025
As European markets continue to rally, with the STOXX Europe 600 Index reaching record levels and major indices like Germany's DAX and France's CAC 40 posting solid gains, investors are keenly observing the impact of anticipated lower U.S. borrowing costs on market sentiment. In this environment of heightened optimism, identifying undervalued stocks becomes crucial for investors seeking potential opportunities amidst broader economic shifts and inflationary pressures in the eurozone.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
Name Current Price Fair Value (Est) Discount (Est) Spindox (BIT:SPN) €12.75 €24.73 48.4% SBO (WBAG:SBO) €27.10 €53.20 49.1% Robit Oyj (HLSE:ROBIT) €1.15 €2.20 47.8% Profoto Holding (OM:PRFO) SEK17.80 SEK35.08 49.3% Lingotes Especiales (BME:LGT) €5.75 €11.22 48.7% Exel Composites Oyj (HLSE:EXL1V) €0.375 €0.72 47.8% Echo Investment (WSE:ECH) PLN5.58 PLN10.71 47.9% Digital Workforce Services Oyj (HLSE:DWF) €3.39 €6.63 48.9% Atea (OB:ATEA) NOK146.00 NOK282.33 48.3% Allegro.eu (WSE:ALE) PLN33.495 PLN66.20 49.4%
Click here to see the full list of 208 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Here's a peek at a few of the choices from the screener.
Thales
Overview: Thales S.A. operates globally, offering solutions in defence and security, aerospace and space, as well as digital identity and security markets, with a market cap of €54.38 billion.
Operations: The company's revenue is primarily derived from its Defence segment at €11.96 billion, followed by Aerospace at €5.81 billion, and Cyber & Digital services contributing €4.08 billion.
Estimated Discount To Fair Value: 26.3%
Thales is trading at €264.80, below its estimated fair value of €359.18, suggesting potential undervaluation based on cash flows. Earnings are forecast to grow 16.8% annually, outpacing the French market's 12.2%. Recent developments include a €450 million EIB loan for R&D in aeronautics and radar technologies and an interim dividend of €0.95 per share for 2025, reflecting ongoing strategic investments and shareholder returns amidst steady revenue growth projections of 7.6% annually.
According our earnings growth report, there's an indication that Thales might be ready to expand. Dive into the specifics of Thales here with our thorough financial health report.ENXTPA:HO Discounted Cash Flow as at Oct 2025
Vimian Group
Overview: Vimian Group AB (publ) operates in the animal health industry globally and has a market cap of SEK15.10 billion.
Operations: The company's revenue is derived from four main segments: Medtech (€142.10 million), Diagnostics (€22.50 million), Specialty Pharma (€178.20 million), and Veterinary Services (€61.60 million).
Story Continues
Estimated Discount To Fair Value: 30.1%
Vimian Group, trading at SEK28.66, is valued below its estimated fair value of SEK41.01, reflecting potential undervaluation based on cash flows. Earnings are expected to grow significantly at 42.55% annually, surpassing the Swedish market's growth rate. Recent earnings report shows a rise in sales to EUR 104.3 million for Q2 2025 from EUR 91 million a year earlier, with net income increasing to EUR 8.3 million from EUR 4.9 million despite leadership changes impacting stability.
Our comprehensive growth report raises the possibility that Vimian Group is poised for substantial financial growth. Click here to discover the nuances of Vimian Group with our detailed financial health report.OM:VIMIAN Discounted Cash Flow as at Oct 2025
Dino Polska
Overview: Dino Polska S.A. operates a network of mid-sized grocery supermarkets under the Dino brand in Poland, with a market cap of PLN42.84 billion.
Operations: The company's revenue primarily comes from sales in its retail network and online platform, totaling PLN31.09 billion.
Estimated Discount To Fair Value: 38%
Dino Polska, trading at PLN43.7, is significantly undervalued with an estimated fair value of PLN70.54, offering potential based on cash flows. Its earnings are projected to grow 20.2% annually, outpacing the Polish market's 15.7%. Recent Q2 results show sales increased to PLN8.62 billion from PLN7.24 billion year-on-year, and net income rose to PLN397.52 million from PLN347.87 million, reflecting strong financial health despite slower revenue growth compared to top-performing peers.
In light of our recent growth report, it seems possible that Dino Polska's financial performance will exceed current levels. Take a closer look at Dino Polska's balance sheet health here in our report.WSE:DNP Discounted Cash Flow as at Oct 2025
Taking Advantage
Reveal the 208 hidden gems among our Undervalued European Stocks Based On Cash Flows screener with a single click here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Simply Wall St is a revolutionary app designed for long-term stock investors, it's free and covers every market in the world.
Seeking Other Investments?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include ENXTPA:HO OM:VIMIAN and WSE:DNP.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- European Growth Companies With High Insider Ownership In September 2025
Sep 24, 2025
In September 2025, the European markets have been navigating a complex economic landscape, with the pan-European STOXX Europe 600 Index ending slightly lower amid a series of monetary policy decisions. As investors assess these developments, growth companies with high insider ownership can offer unique insights into market confidence and potential resilience during such fluctuating times.
Top 10 Growth Companies With High Insider Ownership In Europe
Name Insider Ownership Earnings Growth Pharma Mar (BME:PHM) 11.8% 44.2% MilDef Group (OM:MILDEF) 13.7% 73.8% MedinCell (ENXTPA:MEDCL) 12.5% 91% KebNi (OM:KEBNI B) 38% 63.7% Elliptic Laboratories (OB:ELABS) 24.4% 97.5% CTT Systems (OM:CTT) 17.5% 37.9% Circus (XTRA:CA1) 24.5% 67.1% CD Projekt (WSE:CDR) 13.3% 43.5% Bonesupport Holding (OM:BONEX) 10.4% 59.4% Bergen Carbon Solutions (OB:BCS) 12% 64.6%
Click here to see the full list of 217 stocks from our Fast Growing European Companies With High Insider Ownership screener.
Let's review some notable picks from our screened stocks.
Oryzon Genomics
Simply Wall St Growth Rating: ★★★★★☆
Overview: Oryzon Genomics S.A. is a clinical stage biopharmaceutical company focused on developing epigenetics-based therapeutics for cancer and CNS disorders, with a market cap of approximately €259.43 million.
Operations: The company's revenue is primarily generated from its biotechnology segment, amounting to €7.47 million.
Insider Ownership: 16.9%
Oryzon Genomics, recently added to the S&P Global BMI Index, is poised for significant growth with revenue expected to increase by 56% annually, outpacing the Spanish market. Despite a net loss of €1.59 million in H1 2025 and past shareholder dilution, its strategic focus on innovative treatments like iadademstat for sickle cell disease and oncology trials highlights strong potential. The company's high insider ownership aligns interests with shareholders amid volatile share prices.
Unlock comprehensive insights into our analysis of Oryzon Genomics stock in this growth report. Insights from our recent valuation report point to the potential overvaluation of Oryzon Genomics shares in the market.BME:ORY Earnings and Revenue Growth as at Sep 2025
Devyser Diagnostics
Simply Wall St Growth Rating: ★★★★★☆
Overview: Devyser Diagnostics AB (publ) develops, manufactures, and sells diagnostic kits and solutions for DNA testing in areas such as hereditary diseases, oncology, and post-transplantation monitoring across various regions including Sweden, Europe, the Middle East, Africa, the Americas, and Asia with a market cap of SEK2.61 billion.
Operations: The company's revenue is primarily generated from the sale of diagnostic kits and equipment, amounting to SEK235.10 million.
Story Continues
Insider Ownership: 35.1%
Devyser Diagnostics is set for robust growth with expected annual revenue increases of 27.9%, surpassing the Swedish market average. Recent earnings show a turnaround, moving from a net loss to a net income in Q2 2025, indicating improving financial health. The launch of advanced genomic blood typing and HLA loss detection products underscores its innovation in molecular diagnostics. High insider ownership suggests aligned interests with shareholders as the company targets profitability within three years.
Click here to discover the nuances of Devyser Diagnostics with our detailed analytical future growth report. The valuation report we've compiled suggests that Devyser Diagnostics' current price could be inflated.OM:DVYSR Earnings and Revenue Growth as at Sep 2025
Dino Polska
Simply Wall St Growth Rating: ★★★★★☆
Overview: Dino Polska S.A. operates a network of mid-sized grocery supermarkets under the Dino brand in Poland, with a market cap of PLN45.13 billion.
Operations: Dino Polska generates revenue primarily through its retail network and online sales, amounting to PLN31.09 billion.
Insider Ownership: 30.7%
Dino Polska's strong growth trajectory is highlighted by its earnings, which grew 11% last year and are expected to increase significantly over the next three years, surpassing Polish market averages. The company reported robust sales of PLN 8.62 billion for Q2 2025, up from PLN 7.24 billion a year prior. Trading at a substantial discount to estimated fair value and with high insider ownership, Dino Polska aligns shareholder interests with its promising financial outlook.
Take a closer look at Dino Polska's potential here in our earnings growth report. According our valuation report, there's an indication that Dino Polska's share price might be on the cheaper side.WSE:DNP Ownership Breakdown as at Sep 2025
Taking Advantage
Embark on your investment journey to our 217 Fast Growing European Companies With High Insider Ownership selection here. Looking For Alternative Opportunities? Rare earth metals are the new gold rush. Find out which 30 stocks are leading the charge.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include BME:ORY OM:DVYSR and WSE:DNP.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
View Comments
- European Equity Picks That Might Be Trading Below Fair Value In September 2025
Sep 4, 2025
Amid concerns about the independence of the U.S. Federal Reserve and renewed tariff uncertainties, European markets have faced downward pressure, with major indices like the STOXX Europe 600 Index experiencing declines. As investors navigate these challenging conditions, identifying stocks that might be trading below their fair value can offer potential opportunities for those looking to capitalize on market inefficiencies and long-term growth prospects.
Top 10 Undervalued Stocks Based On Cash Flows In Europe
Name Current Price Fair Value (Est) Discount (Est) Truecaller (OM:TRUE B) SEK43.70 SEK86.05 49.2% Trifork Group (CPSE:TRIFOR) DKK89.90 DKK175.66 48.8% Lingotes Especiales (BME:LGT) €5.90 €11.45 48.5% Lerøy Seafood Group (OB:LSG) NOK47.24 NOK91.69 48.5% DSV (CPSE:DSV) DKK1349.50 DKK2620.71 48.5% cyan (XTRA:CYR) €2.26 €4.44 49% Camurus (OM:CAMX) SEK722.50 SEK1416.78 49% BHG Group (OM:BHG) SEK25.10 SEK50.06 49.9% Alfio Bardolla Training Group (BIT:ABTG) €1.88 €3.67 48.8% Aker BioMarine (OB:AKBM) NOK87.20 NOK169.32 48.5%
Click here to see the full list of 210 stocks from our Undervalued European Stocks Based On Cash Flows screener.
Let's take a closer look at a couple of our picks from the screened companies.
Neste Oyj
Overview: Neste Oyj, with a market cap of €12.44 billion, operates in the production and distribution of renewable diesel and sustainable aviation fuel across Finland, other Nordic countries, the Baltic Rim, various European countries, the United States, and internationally.
Operations: Neste Oyj generates revenue through three main segments: Oil Products (€11.86 billion), Renewable Products (€7.36 billion), and Marketing & Services (€4.38 billion).
Estimated Discount To Fair Value: 14.6%
Neste Oyj is trading at €16.19, slightly below its estimated fair value of €18.96, indicating potential undervaluation based on cash flows. Despite recent volatility and a high debt level, the company is expected to achieve above-average market profit growth over the next three years. Recent earnings showed a net loss for Q2 2025 but highlighted progress in renewable fuel technology with Chevron Lummus Global, which could enhance future profitability and cash flow generation.
Insights from our recent growth report point to a promising forecast for Neste Oyj's business outlook. Delve into the full analysis health report here for a deeper understanding of Neste Oyj.HLSE:NESTE Discounted Cash Flow as at Sep 2025
Dino Polska
Overview: Dino Polska S.A., along with its subsidiaries, operates a network of mid-sized grocery supermarkets under the Dino brand in Poland and has a market cap of PLN45.26 billion.
Operations: The company's revenue primarily comes from sales in its retail network and online sales, amounting to PLN31.09 billion.
Story Continues
Estimated Discount To Fair Value: 36.6%
Dino Polska, trading at PLN 46.16, is significantly undervalued compared to its estimated fair value of PLN 72.78. The company's earnings are projected to grow by 19.4% annually, outpacing the Polish market's growth rate of 13.8%. Recent earnings for Q2 2025 show strong performance with sales reaching PLN 8.62 billion and net income at PLN 397.52 million, reflecting robust revenue growth and potential for enhanced cash flow valuation in the future.
In light of our recent growth report, it seems possible that Dino Polska's financial performance will exceed current levels. Click here to discover the nuances of Dino Polska with our detailed financial health report.WSE:DNP Discounted Cash Flow as at Sep 2025
Basler
Overview: Basler Aktiengesellschaft develops, manufactures, and sells digital cameras for professional users both in Germany and internationally, with a market cap of €527.01 million.
Operations: The company generates revenue primarily from its camera segment, which accounted for €202.37 million.
Estimated Discount To Fair Value: 17.7%
Basler Aktiengesellschaft, trading at €17.14, is undervalued relative to its fair value estimate of €20.82. The company recently raised its earnings guidance for 2025 with projected revenue between €202 million and €215 million, up from previous estimates of up to €198 million. For H1 2025, Basler reported sales of €111.69 million and a net income of €6.46 million compared to a net loss the previous year, highlighting improved cash flow potential despite share price volatility.
Our growth report here indicates Basler may be poised for an improving outlook. Get an in-depth perspective on Basler's balance sheet by reading our health report here.XTRA:BSL Discounted Cash Flow as at Sep 2025
Next Steps
Navigate through the entire inventory of 210 Undervalued European Stocks Based On Cash Flows here. Have you diversified into these companies? Leverage the power of Simply Wall St's portfolio to keep a close eye on market movements affecting your investments. Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.
Want To Explore Some Alternatives?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention. Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence. Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include HLSE:NESTE WSE:DNP and XTRA:BSL.
This article was originally published by Simply Wall St.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com
